SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-23-001811
Filing Date
2023-02-14
Accepted
2023-02-14 16:11:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 TSCAN THERAPEUTICS, INC. p23-0185sc13ga.htm SC 13G/A 44955
  Complete submission text file 0000902664-23-001811.txt   46882
Mailing Address OFFICE #122, WINDWARD 3 BUILDING REGATTA OFFICE PARK, WEST BAY ROAD GRAND CAYMAN E9 KY1-9006
Business Address OFFICE #122, WINDWARD 3 BUILDING REGATTA OFFICE PARK, WEST BAY ROAD GRAND CAYMAN E9 KY1-9006 345-749-8642
HILLHOUSE INVESTMENT MANAGEMENT, LTD. (Filed by) CIK: 0001510589 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Subject) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92700 | Film No.: 23629295
SIC: 2836 Biological Products, (No Diagnostic Substances)